FGF21 and metabolic dysfunction-associated steatotic liver disease: Interestingly, some research suggests that elevated FGF21 levels observed in patients with NAFLD could be independent of PPARα signaling in the liver (193), in contrast to what we understand about fasting-induced hepatic FGF21.